These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15378779)

  • 1. Yeast expression and DNA immunization of hepatitis B virus S gene with second-loop deletion of alpha determinant region.
    Hu H; Peng XM; Huang YS; Gu L; Xie QF; Gao ZL
    World J Gastroenterol; 2004 Oct; 10(20):2989-93. PubMed ID: 15378779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of exogenous multiple epitopes of helper T lymphocytes and DNA immunization of its chimeric plasmid with HBV pre-S2/S gene.
    Gao WJ; Peng XM; Xie DY; Xie QF; Gao ZL; Yao JL
    World J Gastroenterol; 2004 Oct; 10(20):2979-83. PubMed ID: 15378777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity.
    Wu L; He JW; Yao X; Li HM; Wen YM
    J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
    Cooreman MP; Leroux-Roels G; Paulij WP
    J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
    Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Suppression of the antigen-specific T cell immune response by co-immunization with the HBV DNA vaccine and recombinant HBsAg].
    Du X; Wang J; Kang Y; Xiao W; Zhao G; Wang B
    Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):938-42. PubMed ID: 19873759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection.
    Du DW; Jia ZS; Li GY; Zhou YY
    World J Gastroenterol; 2003 Jan; 9(1):108-11. PubMed ID: 12508362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and expression of hepatitis B surface antigen escape variants within the "a" determinant by site directed mutagenesis.
    Golsaz Shirazi F; Amiri MM; Mohammadi H; Bayat AA; Roohi A; Khoshnoodi J; Zarnani AH; Jeddi-Tehrani M; Kardar GA; Shokri F
    Iran J Immunol; 2013 Sep; 10(3):127-38. PubMed ID: 24076590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of exogenous epitopes of helper T lymphocyte on humoral immunity of HBV S gene DNA immunity].
    Peng XM; Xie DY; Gu L; Huang YS; Gao ZL; Yao JL
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):232-6. PubMed ID: 12812669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent.
    Kondo R; Feitelson MA; Strayer DS
    Gene Ther; 1998 May; 5(5):575-82. PubMed ID: 9797861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenicity reduction contributes mostly to poor detectability of HBsAg by hepatitis B virus (HBV) S-gene mutants isolated from individuals with occult HBV infection.
    Zhang K; Liu Y; Chen R; Li Q; Xu Z; Si L; Cheng Y; Yang Y; Chen J; Xu D; Lin S
    J Med Virol; 2018 Feb; 90(2):263-270. PubMed ID: 28876463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to various epitopes of hepatitis B surface antigen inhibit hepatitis B virus infection.
    Golsaz Shirazi F; Mohammadi H; Amiri MM; Singethan K; Xia Y; Bayat AA; Bahadori M; Rabbani H; Jeddi-Tehrani M; Protzer U; Shokri F
    J Gastroenterol Hepatol; 2014 May; 29(5):1083-91. PubMed ID: 24325676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic and immunogenic changes due to mutation of s gene of HBV.
    Ge JH; Liu HM; Sun J; Zhang LZ; He J; Li YL; Liu H; Xu Y; Yu HY; Hu YP
    World J Gastroenterol; 2004 Nov; 10(21):3137-40. PubMed ID: 15457559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation in the S gene a determinant of the hepatitis B virus associated with concomitant HBsAg and anti-HBs in a population in Northeastern Brazil.
    de Campos Albuquerque I; Sousa MT; Santos MD; Nunes JD; Moraes MJ; Gomes-Gouvêa MS; Pinho JR; Carrilho FJ; Fonseca LM; de Sousa Paiva Ferreira A
    J Med Virol; 2017 Mar; 89(3):458-462. PubMed ID: 27486854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.
    Chen Y; Qian F; Yuan Q; Li X; Wu W; Guo X; Li L
    J Clin Virol; 2011 Nov; 52(3):198-203. PubMed ID: 21840251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation on expression of the recombinant S gene of human hepatitis B virus in vitro and in vivo.
    Yang RY; Zeng QP; Fu LC; Chen ZT
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):259-64. PubMed ID: 14599980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication.
    Wu C; Zhang X; Tian Y; Song J; Yang D; Roggendorf M; Lu M; Chen X
    J Gen Virol; 2010 Feb; 91(Pt 2):483-92. PubMed ID: 19812261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation of anti HBs monoclonal antibody and its combination characterization to both wild-type HBsAg and immune escape mutant HBsAg].
    Li FH; Zhang XY; Yan B; Zhang B; Huang YG; Zhang CY; Gong JS; Chen Y; Liu JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):594-6. PubMed ID: 18538091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Aghasadeghi MR; Velayati AA; Mamishi S; Nabavi M; Aghakhani A; Bidari-Zerehpoosh F; Haghi Ashtiani MT; Sabeti S; Banifazl M; Azimian-Zavareh F; Motevalli F; Soleymani S; Ramezani A
    Arch Virol; 2016 Dec; 161(12):3405-3411. PubMed ID: 27613286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg).
    Golsaz-Shirazi F; Amiri MM; Farid S; Bahadori M; Bohne F; Altstetter S; Wolff L; Kazemi T; Khoshnoodi J; Hojjat-Farsangi M; Chudy M; Jeddi-Tehrani M; Protzer U; Shokri F
    Antiviral Res; 2017 Aug; 144():153-163. PubMed ID: 28641998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.